[1] Bekkering S,Arts RJW,Novakovic B,et al.Metabolic induction of trained immunity through the mevalonate pathway[J].Cell,2018,172(1-2):135-146,e9.DOI:10.1016/j.cell.2017.11.025.
[2] Christ A,Günther P,Lauterbach MAR,et al.Western diet triggers NLRP3-dependent innate immune reprogramming[J].Cell,2018,172(1-2):162-175,e14.DOI:10.1016/j.cell.2017.12.013.
[3] O'Neill LA, Kishton RJ, Rathmell J.A guide to immunometabolism for immunologists[J].Nat Rev Immunol,2016,16(9):553-565.DOI:10.1038/nri.2016.70.
[4] Mitroulis I,Ruppova K,Wang B,et al.Modulation of myelopoiesis progenitors is an integral component of trained immunity[J].Cell,2018,172(1-2):147-161,e12.DOI:10.1016/j.cell.2017.11.034.
[5] Saeed S,Quintin J,Kerstens HH,et al.Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity[J].Science,2014,345(6204):1251086.DOI:10.1126/science.1251086.
[6] Cheng SC,Quintin J,Cramer RA,et al.mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity[J].Science,2014,345(6204):1250684.DOI:10.1126/science.1250684.
[7] O'Neill LA,Hardie DG.Metabolism of inflammation limited by AMPK and pseudo-starvation[J].Nature,2013,493(7432):346-355.DOI:10.1038/nature11862.
[8] Németh B,Doczi J,Csete D,et al.Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage[J].FASEB J,2016,30(1):286-300.DOI:10.1096/fj.15-279398.
[9] Tannahill GM,Curtis AM,Adamik J,et al.Succinate is an inflammatory signal that induces IL-1β through HIF-1α[J].Nature,2013,496(7444):238-242.DOI:10.1038/nature11986.
[10] Cordes T,Wallace M,Michelucci A,et al.Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels[J].J Biol Chem,2016,291(27):14274-14284.DOI:10.1074/jbc.M115.685792.
[11] Lampropoulou V,Sergushichev A,Bambouskova M,et al.Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation[J].Cell Metab,2016,24(1):158-166.DOI:10.1016/j.cmet.2016.06.004.
[12] Arts RJ,Novakovic B,Ter Horst R,et al.Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity[J].Cell Metab,2016,24(6):807-819.DOI:10.1016/j.cmet.2016.10.008.
[13] Sikalidis AK.Amino acids and immune response: a role for cysteine, glutamine, phenylalanine, tryptophan and arginine in T-cell function and cancer?[J].Pathol Oncol Res,2015,21(1):9-17.DOI:10.1007/s12253-014-9860-0.
[14] Quintin J,Saeed S,Martens JHA,et al.Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes[J].Cell Host Microbe,2012,12(2):223-232.DOI:10.1016/j.chom.2012.06.006.
[15] Israël M,Schwartz L.The metabolic advantage of tumor cells[J].Mol Cancer,2011,10:70.DOI:10.1186/1476-4598-10-70.
[16] O'Neill LA,Hardie DG.Metabolism of inflammation limited by AMPK and pseudo-starvation[J].Nature,2013,493(7432):346-355.DOI:10.1038/nature11862.
[17] Lum JJ,Bui T,Gruber M,et al.The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis[J].Genes Dev,2007,21(9):1037-1049.DOI:10.1101/gad.1529107.
[18] Tennant DA,Durán RV,Gottlieb E.Targeting metabolic transformation for cancer therapy[J].Nat Rev Cancer,2010,10(4):267-277.DOI:10.1038/nrc2817.
[19] Elia I,Schmieder R,Christen S,et al.Organ-specific cancer metabolism and its potential for therapy[J].Handb Exp Pharmacol,2016,233:321-353.DOI:10.1007/164_2015_10.
[20] Bekkering S,Quintin J,Joosten LA,et al.Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes[J].Arterioscler Thromb Vasc Biol,2014,34(8):1731-1738.DOI:10.1161/ATVBAHA.114.303887.
[21] Ruiz-Núñez B,Dijck-Brouwer DA,Muskiet FA.The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease[J].J Nutr Biochem,2016,36:1-20.DOI:10.1016/j.jnutbio.2015.12.007.
[22] Levy O.Innate immunity of the newborn: basic mechanisms and clinical correlates[J].Nat Rev Immunol,2007,7(5):379-390.DOI:10.1038/nri2075.
[23] Ter Steeg L,Domínguez-Andrés J,Netea MG,et al.Trained immunity as a preventive measure for surgical site infections[J].Clin Microbiol Rev,2021,34(4):e0004921.DOI:10.1128/CMR.00049-21.
[24] van Diepen JA,Thiem K,Stienstra R,et al.Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?[J].Cell Mol Life Sci,2016,73(24):4675-4684.DOI:10.1007/s00018-016-2316-9.
[25] Kopanakis K,Tzepi IM,Pistiki A,et al.Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coli[J].Cytokine,2013,62(3):382-388.DOI:10.1016/j.cyto.2013.03.028.
[26] Brandau S,Suttmann H.Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement[J].Biomed Pharmacother,2007,61(6):299-305.DOI:10.1016/j.biopha.2007.05.004.
[27] Stevens NE,van Wolfswinkel M,Bao W,et al.Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice[J].Vaccine,2022,40(11):1594-1605.DOI:10.1016/j.vaccine.2021.03.084.
[28] Geckin B,Konstantin Föhse F,Domínguez-Andrés J,et al.Trained immunity: implications for vaccination[J].Curr Opin Immunol,2022,77:102190.DOI:10.1016/j.coi.2022.102190.
|